[1] Sung H, Ferlay J, Siegel RL, Laversanne M, Soerjomataram I, Jemal A, et al. Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries. CA: A Cancer Journal for Clinicians 2021;71:209 – 49.
[2] CANCER STATISTICS IN JAPAN 2021 n.d.
[3] Hunter KD, Parkins on EK, Harrison PR. Profiling early head and neck cancer. Nat Rev Cancer 2005;5:127 – 35.
[4] Forastiere A, Koch W, Trotti A, Sidransky D. Head and neck cancer. N Engl J Med 2001;345 :1890 – 900.
[5] Gil Z, Carlson DL, Boyle JO, Kraus DH, Shah JP, Shaha AR, et al. Lymph node density is a significant predictor of outcome in patients with oral cancer. Cancer 2009;115:5700 – 10.
[6] Mamelle G, Pampurik J, Luboinski B, Lancar R , Lusinchi A , Bosq J. Lymph node prognostic factors in head and neck squamous cell carcinom as. Am J Surg 1994;168:494 – 8 .
[7] Guarino M, Rubino B, Ballabio G. The role of epithelial - mesenchymal transition in cancer pathology. Pathology 2007;39:305 – 18.
[8] Joyce JA, Pollard JW. Microenvironmental regulation of metastasis. Nat Rev Cancer 2009;9:239 – 52.
[9] Morita Y, Hata K , Nakanishi M , Omata T, Morita N , Yura Y, et al . Cellular fibronectin 1 promotes VEGF - C expression, lymphangio - genesis and lymph node metastasis associated with human oral squamous cell carcinoma. Clinical and Experimental Metastasis 2015; 32:739 – 53.
[10] Maeda M, Ohashi K, Ohashi - Kobayashi A. Further extension of mammalian GATA - 6. Development, Growth & Differentiation 2005; 47:591 – 600.
[11] Sulahian R, Casey F, Shen J, Qian ZR, Shin H, Ogino S, et al. An inte grative analysis reveals functional targets of GATA6 transcriptional regulation in gastric cancer. Oncogene 2014;33:5637 – 48.
[12] Chen WB , Huang FT, Zhuang YY, Tang J , Zhuang XH, Cheng WJ, et al. Silencing of GATA6 suppresses SW1990 pancreatic cancer cell growth in vitro and up - regulates reactive oxygen species. Digestive Diseases and Sciences 2013;58:2518 – 27.
[13] Cai WS, Shen F, Li JL, Feng Z, Wang YC, Xiao HQ, et al. Activated protease receptor - 2 induces GATA6 expression to promote survival in irradiat ed colon cancer cells. Archives of Biochemistry and Biophysics 2014;555 – 556:28 – 32.
[14] Whissell G, Montagni E, Martinelli P, Hernando - Momblona X, Sevillano M, Jung P, et al. The transcription factor GATA6 enables self - renewal of colon adenoma stem cells by repressing BMP gene expression. Nature Cell Biology 2014;16:695 – 707.
[15] Martinelli P, Carrillo - De Santa Pau E, Cox T, Sainz B, Dusetti N, Greenhalf W, et al. GATA6 regulates EMT and tumour dissemination, and is a marker of response to adjuvant chemot herapy in pancreatic cancer. Gut 2017;66:1665 – 76.
[16] D e n g X , J i a n g P, C h e n J , L i J , L i D , H e Y, et al. GATA6 promotes epithelial - mesenchymal transition and metastasis through MUC1/ β - catenin pathway in cholangiocarcinoma. Cell Death & Disease 2020;11.
[ 17] Momose F, Araida T, Negishi A, Ichijo H, Shioda S, Sasaki S. Variant sublines with different metastatic potentials selected in nude mice from human oral squamous cell carcinomas. Journal of Oral Pathology & Medicine : Official Publication of the Intern ational Association of Oral Pathologists and the American Academy of Oral Pathology 1989;18:391 – 5.
[18] Urade M, Ogura T, Mima T, Matsuya T. Establishment of human squamous carcinoma cell lines highly and minimally sensitive to bleomycin and analysis of f actors involved in the sensitivity. Cancer 1992;69:2589 – 97.
[19] Sugiyama A, Ishiguro M, Yasue T, Watanabe S, Sugishita N, Yokoyama H, et al. [An autopsy case of triple cancer associated with superior vena cava syndrome]. Gan no rinsho Japan journal of cancer clinics 1985 ; 31 : 1347 – 52.
[20] Okabe T, Sato N , Kondo Y, Asano S , Ohsawa N , Kosaka K , et al . Establishment and Charac-terization of a Human Cancer Cell Line That Produces Human Colony - stimulating Factor. Cancer Research 1978;38.
[21] Horikoshi M, Kimur a Y, Nagura H , Ono T, Ito H. [A new human cell line derived from human carcinoma of the gingiva. I. Its establishment and morphological studies]. Nihon Koku Geka Gakkai Zasshi 1974;20:100 – 6.
[22] Harada M, Miyata K, Wada T, Ohmata T, Morita N, Sakamoto T. Establishment and characterization of a cell line (Sa3) from squamous cell carcinoma of the human gingiva. Japanese Journal of Oral & Maxillofacial Surgery 1993;39:965 – 71.
[23] Morita Y, Hata K , Nakanishi M , Nishisho T, Yura Y, Yoneda T. Cyclooxygenase-2 promotes tumor lymphangiogenesis and lymph node metastasis in oral squamous cell carcinoma. Int J Oncol 2012;41:885 – 92.
[24] Park MA, Jung HS, Slukvin I. Genetic Engineering of Human Pluripotent Stem Cells Using PiggyBac Transposon System. Current Protoco ls in Stem Cell Biology 2018;47.
[25] Trapnell C, Williams BA, Pertea G, Mortazavi A, Kwan G, van Baren MJ, et al. Transcript assembly and quantification by RNA - Seq reveals unannotated transcripts and isoform switching during cell different - iation. Nature Biotechnology 2010;28:511 – 5.
[26] Shintani S , Mihara M , Nakahara Y, Kiyota A , Ueyama Y, Matsumura T, et al . Expression of cell cycle control proteins in normal epithelium, premalignant and malignant lesions of oral cavity. Oral Oncol 2002;38:235 – 43.
[27] Scanlon CS, van Tubergen EA, Inglehart RC, D’Silva NJ. Biomarkers of epithelial - mesenchymal transition in squamous cell carcinoma. Journal of Dental Research 2013;92:114 – 21.
[28] Deng L, Liu H. MicroRNA - 506 suppresses growth and metastasis of oral sq uamous cell carcinoma via targeting GATA6. International Journal of Clinical and Experimental Medicine 2015;8:1862.
[29] Xu CL , Guan WQ , Wang XY. The expression of the GATA6 gene in oral carcinoma cell lines. World Journal of Surgical Oncology 2021;19.
[30] Song Y, Tian T, FuX , Wang W, LiS , Shi T, et al. GATA6 is overexpressed in breast cancer and promotes breast cancer cell epithelial - mesenchymal transition by upregulating slug expression. Experimental and Molecular Pathology 2015;99:617 – 27.
[31] Tian F, Chen J , Zheng S , Li D, Zhao X, Jiang P, et al. miR - 124 targets GATA6 to suppress cholangiocarcinoma cell invasion and metastasis. BMC Cancer 2017;17.
[32] Tian F, Li D, Chen J, Liu W, Cai L, Li J, et al. Aberrant expression of GATA binding protein 6 correlates with poor prognosis and promotes metastasis in cholangiocarcinoma. European Journal of Cancer (Oxford, England : 1990) 2013;49:1771 – 80.
[33] Tang JT, Gao W, Liu G, Sheng WW, Zhou JP, Dong Q, et al. miR - 944 Suppresses EGF - Induced EMT in Colorectal Cancer Cells by Directly Targeting GATA6. OncoTargets and Therapy 2021;14:2311 – 25.
[34] Gerke V, Moss SE . Annexins : from structure to function. Physiological Reviews 2002;82: 331 – 71.
[35] Gerke V, Creutz CE , Moss SE . Annexins : linking Ca 2 + signalling to membrane dynamics. Nature Reviews Molecular Cell Biology 2005;6:449 – 61.
[36] Kodaira H , ichiro Koma Y, Hosono M , Higashino N, Suemune K, Nishio M, et al. ANXA10 induction by interaction with tumor - associated macrophages promotes the growth of esophageal s quamous cell carcinoma. Pathology International 2019;69:135 – 47.
[37] Munksgaard PP, Mansilla F, Brems Eskildsen AS, Fristrup N, Birkenkamp - Demtröder K, Ulhøi BP, et al. Low ANXA10 expression is associated with disease aggressiveness in bladder cancer. Bri tish Journal of Cancer 2011;105:1379 – 87.
[38] Sun R, Liu Z, Qiu B, Chen T, Li Z, Zhang X, et al. Annexin10 promotes extrahepatic cholangiocarcinoma metastasis by facilitating EMT via PLA2G4A/PGE2/STAT3 pathway. EBioMedicine 2019;47:142 – 55.
[39] Wang J, Zhao S , Wang F, Wang J , Zhang Y. Prognostic Significance of Increased Expression of Annexin A10 (ANXA10) in Serous Epithelial Ovarian Cancer. Medical Science Monitor: International Medical Journal of Experimental and Clinical Research 2019;25: 5666 – 73.
[40] Zhu J, Wu J, Pei X, Tan Z, Shi J, Lubman DM. Annexin A10 is a candidate marker associated with the progression of pancreatic precursor lesions to adenocarcinoma. PloS One 2017;12.
[41] Shimizu T, Kasamatsu A, Yamamoto A, Koike K, Ishige S, Takatori H, et al. Annexin A10 in human oral cancer: biomarker for tumoral growth via G1/S transition by targeting MAPK signaling pathways. PloS One 2012;7.
[42] Miyazawa Y, Sekine Y, Kato H , Furuya Y, Koike H, Suzuki K. Simvastatin Up - Regulates Annexin A10 That Can In hibit the Proliferation, Migration, and Invasion in Androgen - Independent Human Prostate Cancer Cells; Simvastatin Up - Regulates Annexin A10 That Can Inhibit the Proliferation , Migration , and Invasion in Androgen - Independent Human Prostate Cancer Cells. Prostate 2017;77:337 – 49.
[43] Lu S - H, Yuan R - H, Chen Y - L, Hsu H - C, Jeng Y - M et al. Annexin A10 is an immune histochemical marker for adeno - carcinoma of the upper gastrointestinal tract and pancreatobiliary system 2013.